A citation-based method for searching scientific literature

Archie Bleyer, H Gilbert Welch. N Engl J Med 2012
Times Cited: 770







List of co-cited articles
400 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.
Freddie Bray, Jacques Ferlay, Isabelle Soerjomataram, Rebecca L Siegel, Lindsey A Torre, Ahmedin Jemal. CA Cancer J Clin 2018
15



Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
H Gilbert Welch, Philip C Prorok, A James O'Malley, Barnett S Kramer. N Engl J Med 2016
270
9

Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society.
Kevin C Oeffinger, Elizabeth T H Fontham, Ruth Etzioni, Abbe Herzig, James S Michaelson, Ya-Chen Tina Shih, Louise C Walter, Timothy R Church, Christopher R Flowers, Samuel J LaMonte,[...]. JAMA 2015
725
7

Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ - The LORD study.
Lotte E Elshof, Konstantinos Tryfonidis, Leen Slaets, A Elise van Leeuwen-Stok, Victoria P Skinner, Nicolas Dif, Ruud M Pijnappel, Nina Bijker, Emiel J Th Rutgers, Jelle Wesseling. Eur J Cancer 2015
170
6


The benefits and harms of breast cancer screening: an independent review.
M G Marmot, D G Altman, D A Cameron, J A Dewar, S G Thompson, M Wilcox. Br J Cancer 2013
434
6

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually.
M H Gail, L A Brinton, D P Byar, D K Corle, S B Green, C Schairer, J J Mulvihill. J Natl Cancer Inst 1989
6

Effectiveness of Breast Cancer Screening: Systematic Review and Meta-analysis to Update the 2009 U.S. Preventive Services Task Force Recommendation.
Heidi D Nelson, Rochelle Fu, Amy Cantor, Miranda Pappas, Monica Daeges, Linda Humphrey. Ann Intern Med 2016
217
6


Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study.
Laura C Collins, Rulla M Tamimi, Heather J Baer, James L Connolly, Graham A Colditz, Stuart J Schnitt. Cancer 2005
166
5

Molecular portraits of human breast tumours.
C M Perou, T Sørlie, M B Eisen, M van de Rijn, S S Jeffrey, C A Rees, J R Pollack, D T Ross, H Johnsen, L A Akslen,[...]. Nature 2000
5


Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
180
5

Breast Cancer Screening, Incidence, and Mortality Across US Counties.
Charles Harding, Francesco Pompei, Dmitriy Burmistrov, H Gilbert Welch, Rediet Abebe, Richard Wilson. JAMA Intern Med 2015
116
5

Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
303
5

Cancer statistics, 2019.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2019
5

Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Evan R Myers, Patricia Moorman, Jennifer M Gierisch, Laura J Havrilesky, Lars J Grimm, Sujata Ghate, Brittany Davidson, Ranee Chatterjee Mongtomery, Matthew J Crowley, Douglas C McCrory,[...]. JAMA 2015
250
5


Breast Cancer Screening in Denmark: A Cohort Study of Tumor Size and Overdiagnosis.
Karsten Juhl Jørgensen, Peter C Gøtzsche, Mette Kalager, Per-Henrik Zahl. Ann Intern Med 2017
73
6

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.
Irene L Wapnir, James J Dignam, Bernard Fisher, Eleftherios P Mamounas, Stewart J Anderson, Thomas B Julian, Stephanie R Land, Richard G Margolese, Sandra M Swain, Joseph P Costantino,[...]. J Natl Cancer Inst 2011
427
5

Effect of screening and adjuvant therapy on mortality from breast cancer.
Donald A Berry, Kathleen A Cronin, Sylvia K Plevritis, Dennis G Fryback, Lauren Clarke, Marvin Zelen, Jeanne S Mandelblatt, Andrei Y Yakovlev, J Dik F Habbema, Eric J Feuer. N Engl J Med 2005
5

Cancer statistics, 2018.
Rebecca L Siegel, Kimberly D Miller, Ahmedin Jemal. CA Cancer J Clin 2018
5

Rethinking screening for breast cancer and prostate cancer.
Laura Esserman, Yiwey Shieh, Ian Thompson. JAMA 2009
378
5

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
359
4

Overdiagnosis in cancer.
H Gilbert Welch, William C Black. J Natl Cancer Inst 2010
997
4

Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ.
Lotte E Elshof, Marjanka K Schmidt, Emiel J Th Rutgers, Flora E van Leeuwen, Jelle Wesseling, Michael Schaapveld. Ann Surg 2018
29
13

Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study.
Philippe Autier, Magali Boniol, Alice Koechlin, Cécile Pizot, Mathieu Boniol. BMJ 2017
49
8

Breast cancer statistics, 2017, racial disparity in mortality by state.
Carol E DeSantis, Jiemin Ma, Ann Goding Sauer, Lisa A Newman, Ahmedin Jemal. CA Cancer J Clin 2017
799
4

Global Cancer Incidence and Mortality Rates and Trends--An Update.
Lindsey A Torre, Rebecca L Siegel, Elizabeth M Ward, Ahmedin Jemal. Cancer Epidemiol Biomarkers Prev 2016
4

Interpreting overdiagnosis estimates in population-based mammography screening.
Rianne de Gelder, Eveline A M Heijnsdijk, Nicolien T van Ravesteyn, Jacques Fracheboud, Gerrit Draisma, Harry J de Koning. Epidemiol Rev 2011
135
4

Beyond mammography: new frontiers in breast cancer screening.
Jennifer S Drukteinis, Blaise P Mooney, Chris I Flowers, Robert A Gatenby. Am J Med 2013
73
5


Screening for Breast Cancer in Average-Risk Women: A Guidance Statement From the American College of Physicians.
Amir Qaseem, Jennifer S Lin, Reem A Mustafa, Carrie A Horwitch, Timothy J Wilt, Mary Ann Forciea, Nick Fitterman, Alfonso Iorio, Devan Kansagara, Michael Maroto,[...]. Ann Intern Med 2019
60
6

Breast Cancer Screening for Average-Risk Women: Recommendations From the ACR Commission on Breast Imaging.
Debra L Monticciolo, Mary S Newell, R Edward Hendrick, Mark A Helvie, Linda Moy, Barbara Monsees, Daniel B Kopans, Peter R Eby, Edward A Sickles. J Am Coll Radiol 2017
93
4

Recommendations on screening for breast cancer in women aged 40-74 years who are not at increased risk for breast cancer.
Scott Klarenbach, Nicki Sims-Jones, Gabriela Lewin, Harminder Singh, Guylène Thériault, Marcello Tonelli, Marion Doull, Susan Courage, Alejandra Jaramillo Garcia, Brett D Thombs. CMAJ 2018
69
5

Benefits and harms of mammography screening.
Magnus Løberg, Mette Lise Lousdal, Michael Bretthauer, Mette Kalager. Breast Cancer Res 2015
106
4

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.
Soonmyung Paik, Steven Shak, Gong Tang, Chungyeul Kim, Joffre Baker, Maureen Cronin, Frederick L Baehner, Michael G Walker, Drew Watson, Taesung Park,[...]. N Engl J Med 2004
4

Estimation of the Number of Women Living with Metastatic Breast Cancer in the United States.
Angela B Mariotto, Ruth Etzioni, Marc Hurlbert, Lynne Penberthy, Musa Mayer. Cancer Epidemiol Biomarkers Prev 2017
204
4


Overview of the randomized trials of radiotherapy in ductal carcinoma in situ of the breast.
C Correa, P McGale, C Taylor, Y Wang, M Clarke, C Davies, R Peto, N Bijker, L Solin, S Darby. J Natl Cancer Inst Monogr 2010
365
4

Delays in Breast Cancer Detection and Treatment in Developing Countries.
Monica M Rivera-Franco, Eucario Leon-Rodriguez. Breast Cancer (Auckl) 2018
67
5

Rate of over-diagnosis of breast cancer 15 years after end of Malmö mammographic screening trial: follow-up study.
Sophia Zackrisson, Ingvar Andersson, Lars Janzon, Jonas Manjer, Jens Peter Garne. BMJ 2006
230
4

Screening for breast cancer with mammography.
Peter C Gøtzsche, Karsten Juhl Jørgensen. Cochrane Database Syst Rev 2013
420
4

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications.
T Sørlie, C M Perou, R Tibshirani, T Aas, S Geisler, H Johnsen, T Hastie, M B Eisen, M van de Rijn, S S Jeffrey,[...]. Proc Natl Acad Sci U S A 2001
4

Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer.
Peter Schmid, Sylvia Adams, Hope S Rugo, Andreas Schneeweiss, Carlos H Barrios, Hiroji Iwata, Véronique Diéras, Roberto Hegg, Seock-Ah Im, Gail Shaw Wright,[...]. N Engl J Med 2018
4


Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation.
Mark Robson, Seock-Ah Im, Elżbieta Senkus, Binghe Xu, Susan M Domchek, Norikazu Masuda, Suzette Delaloge, Wei Li, Nadine Tung, Anne Armstrong,[...]. N Engl J Med 2017
4

Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation.
Jennifer K Litton, Hope S Rugo, Johannes Ettl, Sara A Hurvitz, Anthony Gonçalves, Kyung-Hun Lee, Louis Fehrenbacher, Rinat Yerushalmi, Lida A Mina, Miguel Martin,[...]. N Engl J Med 2018
624
4


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.